Holen Sie sich die Stockscreener-App
195.96
0.51%
1.00
Handel nachbörslich:
195.96
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt BDX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Becton Dickinson Co Aktie (BDX) Neueste Nachrichten
Clinical Microbiology Market to Reach $6.9 Billion by 2029, Driven by Advanced Diagnostics and Regulatory Demand | MarketsandMarkets™. - GlobeNewswire Inc.
Diamond Hill Capital's Strategic Moves: Significant Reduction in Becton Dickinson & Co - Yahoo Finance
Director’s Bold Move: A Million-Dollar Bet on Becton Dickinson! - TipRanks
Judge OKs Becton Dickinson's $9M Investor Settlement - Law360
4 Overlooked Dividend Aristocrat Stocks with Up To 60%+ Growth Potential - 24/7 Wall St.
BD Careers | Jobs at BD | We are the Makers of Possible - Becton Dickinson
Earnings Beat: Becton, Dickinson and Company Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - 富途牛牛
Piper Sandler Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Raises Target Price to $200 - 富途牛牛
Director Makes Significant Move with Becton Dickinson Stock! - TipRanks
J.P. Morgan Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Raises Target Price to $190 - 富途牛牛
A Quick Look at Today's Ratings for Becton Dickinson & Co(BDX.US), With a Forecast Between $183 to $200 - 富途牛牛
Becton Dickinson: Wells Fargo maintains Equal-Weight, raises PT to $184 from $172. - AInvest
Becton, Dickinson and Company (NYSE:BDX) Q3 2025 Earnings Call Transcript - Insider Monkey
Becton Dickinson price target raised to $200 from $185 at Piper Sandler - TipRanks
Piper Sandler raises Becton Dickinson stock price target to $200 on earnings beat - Investing.com
Becton Dickinson & Co (BDX) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Becton Dickinson Reports Strong Q3 2025 Results - TipRanks
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MSN
Becton, Dickinson and Co’s Optimistic Earnings Call - TipRanks
Becton Dickinson: Fiscal Q3 Earnings Snapshot - Chron
Becton Dickinson and Co reports results for the quarter ended June 30Earnings Summary - TradingView
Becton Dickinson Q3 Beats Estimates On Medical Device Boom - inkl
Earnings call transcript: Becton Dickinson Q3 2025 earnings beat forecasts, stock surges - Investing.com
Becton Dickinson Earnings: Return to Organic Growth; Raised EPS Guidance; Shares Remain Undervalued - Morningstar
Becton, Dickinson stock rises on Q3 beat (BDX:NYSE) - Seeking Alpha
Becton, Dickinson and Company 2025 Q3ResultsEarnings Call Presentation (NYSE:BDX) - Seeking Alpha
Becton, Dickinson Boosts FY25 Adj. EPS OutlookUpdate - Nasdaq
Becton Dickinson Q3 FY25 presentation: Organic growth accelerates, guidance raised - Investing.com India
BD raises 2025 EPS guidance after strong Q3 performance - MassDevice
Becton Dickinson & Co Surpasses Q3 Estimates with $5.5 Billion Revenue and $3.68 Adjusted EPS - GuruFocus
Becton Dickinson shares surge as Q3 earnings beat drives guidance hike - Investing.com Nigeria
Becton Dickinson & Co Surpasses Q3 Estimates with $5.5 Billion R - GuruFocus
Becton Dickinson earnings beat by $0.28, revenue topped estimates - Investing.com
Becton, Dickinson and Company Submits Application to the FDA for a New, At-Home HPV Test - Insider Monkey
First Eagle Investment's Strategic Moves: Spotlight on Becton Dickinson & Co - Yahoo Finance
Becton, Dickinson Q3 2025 Earnings Preview - MSN
Is Becton Dickinson (NYSE:BDX) A Risky Investment? - 富途牛牛
Stock Analysis | Becton, Dickinson OutlookA Cautious Call Amid Mixed Technical and Analyst Signals - AInvest
Becton Dickinson Stock Dips 1.12% as Volume Jumps 38.71% to $510M Ranking 232nd Amid Historic Supply Chain Certification - AInvest
Medical Giant BD Achieves Unprecedented Supply Chain Excellence with Perfect Score Across All 7 HIRC Categories - Stock Titan
Becton Dickinson & Co(BDX.US) Officer Sells US$514.14K in Common Stocks - 富途牛牛
BD to invest $35M to expand Nebraska syringe manufacturing - MassDevice
BD invests $35M to expand syringe plant in Nebraska - NJBIZ
Reshoring and Supply Chain Resilience: BD's Strategic Expansion in U.S. Medical Device Manufacturing and Its Implications for Long-Term Value Creation - AInvest
BD to Invest $35 Million in Nebraska Facility - citybiz
$35M Investment: BD Boosts Critical US Medical Supply Chain with Major Nebraska Factory Expansion - Stock Titan
Covington resident wins $20 million in case against Becton Dickinson - The Covington News
Becton Dickinson Stock Dives 1.81% Amid 100.16% Volume Spike to $670M Ranking 199th in Market Activity as FDA Submission Drives Volatility - AInvest
Earnings Preview: Becton Dickinson (BDX) Q3 Earnings Expected to Decline - Yahoo Finance
BD receives FDA clearance for rapid point-of-care COVID-19 test By Investing.com - Investing.com South Africa
BD receives FDA clearance for rapid point-of-care COVID-19 test - Investing.com
Becton Dickinson receives FDA clearance for BD Veritor System for SARS-CoV-2 - TipRanks
BD's New FDA-Cleared COVID Test Delivers Results in Just 15 Minutes: What Healthcare Providers Should Know - Stock Titan
Former Masimo COO Bilal Muhsin Joins BD - Orange County Business Journal
Is Becton Dickinson and Company stock overvalued or undervaluedBuild wealth faster with high-performing stocks - jammulinksnews.com
What are analysts’ price targets for Becton Dickinson and Company in the next 12 monthsAchieve breakthrough financial growth - jammulinksnews.com
0.52%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):